LANNETT COMPANY, INC

LCIUnited States

32 filed reports · 438 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$341M

FY2022 · to Jun 30, 2022

down −28.9% vs $479M

10-K

Net income

-$232M

FY2022 · to Jun 30, 2022

a year earlier: -$363M

10-K

Operating income

-$176M

FY2022 · to Jun 30, 2022

a year earlier: -$237M

10-K

Latest quarter

Revenue

$80.5M

Q3 FY2023 · to Mar 31, 2023

up +2.7% vs $78.4M

10-Q

Net income

-$101M

Q3 FY2023 · to Mar 31, 2023

a year earlier: -$34.9M

10-Q

Operating income

-$86.7M

Q3 FY2023 · to Mar 31, 2023

a year earlier: -$22.1M

10-Q

Filed reports

32 reports · Jun 2015 to Mar 2023

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR244,717Oct 2015 to Mar 2023
Annual · 10-KSEC EDGAR83,945Jun 2015 to Jun 2022

Documents

PeriodTypePeriod endPublishedFactsSource
FY2023 Q310-Q2023-03-312023-05-15367Open
FY2023 Q210-Q2022-12-312023-02-02259Open
FY2023 Q110-Q2022-09-302022-11-03251Open
FY202210-K2022-06-302022-08-25798Open
FY2022 Q310-Q2022-03-312022-05-10183Open
FY2022 Q210-Q2021-12-312022-02-04179Open
FY2022 Q110-Q2021-09-302021-11-04182Open
FY202110-K2021-06-302021-08-26413Open
FY2021 Q310-Q2021-03-312021-05-06179Open
FY2021 Q210-Q2020-12-312021-02-04175Open
FY2021 Q110-Q2020-09-302020-11-05186Open
FY202010-K2020-06-302020-08-27487Open

Financial data

438 concepts · 8,662 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial431 concepts · 7,905 facts · Sep 2012 to Mar 2023

  • Gross profit (US GAAP)53 · Sep 2012 to Mar 2023
  • Income tax expense benefit53 · Sep 2012 to Mar 2023
  • Operating expenses (US GAAP)53 · Sep 2012 to Mar 2023
  • Operating income loss53 · Sep 2012 to Mar 2023
  • Other nonoperating income expense53 · Sep 2012 to Mar 2023
  • Revenue53 · Sep 2012 to Mar 2023
  • Earnings per share basic51 · Sep 2012 to Mar 2023
  • Earnings per share diluted51 · Sep 2012 to Mar 2023
  • Cash and cash equivalents at carrying value48 · Jun 2013 to Mar 2023
  • Accumulated other comprehensive income loss net of tax46 · Jun 2014 to Mar 2023
  • Allocated share based compensation expense45 · Jun 2013 to Mar 2023
  • Defined contribution plan cost recognized45 · Jun 2013 to Mar 2023
  • Depreciation45 · Jun 2013 to Mar 2023
  • Depreciation depletion and amortization45 · Jun 2013 to Mar 2023
  • Increase decrease in accounts payable45 · Jun 2013 to Mar 2023
  • Increase decrease in accounts receivable45 · Jun 2013 to Mar 2023
  • Increase decrease in accrued liabilities45 · Jun 2013 to Mar 2023
  • Increase decrease in employee related liabilities45 · Jun 2013 to Mar 2023
  • Increase decrease in inventories45 · Jun 2013 to Mar 2023
  • Increase (Decrease) in Rebates Chargebacks and Returns Payable45 · Jun 2013 to Mar 2023
  • Interest expense (US GAAP)45 · Jun 2013 to Mar 2023
  • Payments to acquire property plant and equipment45 · Jun 2013 to Mar 2023
  • Proceeds from issuance of shares under incentive and share based compensation plans including stock options45 · Jun 2013 to Mar 2023
  • Profit loss45 · Jun 2013 to Mar 2023

Product4 concepts · 750 facts · Jun 2013 to Mar 2023

  • Revenue525 · Jun 2013 to Mar 2023
  • Sales Revenue Excluding Settlement Expenses223 · Mar 2015 to Jun 2018
  • Contingency entitys patents valid1 · Sep 2018
  • Impairment of intangible assets excluding goodwill1 · Mar 2020

Segment3 concepts · 7 facts · Mar 2016 to Mar 2017

  • Goodwill acquired during period3 · Mar 2016 to Jun 2016
  • Goodwill purchase accounting adjustments3 · Sep 2016 to Mar 2017
  • Business Combination Measurement Period Adjustment To Revenue Related Returns Reserve1 · Sep 2016

Segments

757 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or serviceus-gaap:ProductOrServiceAxis18 members · 441 facts

  • Antibiotic32 · Jun 2013 to Mar 2019
  • Gallstone32 · Jun 2013 to Mar 2019
  • Glaucoma32 · Jun 2013 to Mar 2019
  • Migraine32 · Jun 2013 to Mar 2019
  • Pain Management32 · Jun 2013 to Mar 2019
  • Thyroid Deficiency32 · Jun 2013 to Mar 2019
  • Cardiovascular31 · Jun 2013 to Mar 2019
  • Other31 · Jun 2013 to Mar 2019
  • Muscle Relaxant30 · Sep 2014 to Mar 2019
  • Urinary25 · Jun 2015 to Mar 2019
  • Central Nervous System24 · Sep 2015 to Mar 2019
  • Gastrointestinal24 · Sep 2015 to Mar 2019
  • Respiratory24 · Sep 2015 to Mar 2019
  • Anti Psychosis22 · Jun 2015 to Mar 2019
  • Obesity21 · Jun 2013 to Jun 2017
  • Gout10 · Jun 2013 to Jun 2016
  • Contract manufacturing revenue6 · Sep 2017 to Mar 2019
  • Zomig1 · Sep 2018

Product or servicesrt:ProductOrServiceAxis20 members · 309 facts

  • Anti Psychosis25 · Jun 2017 to Mar 2023
  • Cardiovascular25 · Jun 2017 to Mar 2023
  • Central Nervous System25 · Jun 2017 to Mar 2023
  • Contract manufacturing revenue25 · Jun 2017 to Mar 2023
  • Gastrointestinal25 · Jun 2017 to Mar 2023
  • Migraine25 · Jun 2017 to Mar 2023
  • Other25 · Jun 2017 to Mar 2023
  • Analgesic24 · Jun 2018 to Mar 2023
  • Infectious Disease24 · Jun 2018 to Mar 2023
  • Respiratory/Allergy/Cough/Cold24 · Jun 2018 to Mar 2023
  • Urinary22 · Jun 2017 to Jun 2022
  • Endocrinology18 · Jun 2018 to Mar 2023
  • Antibiotic3 · Jun 2017 to Jun 2019
  • Gallstone3 · Jun 2017 to Jun 2019
  • Glaucoma3 · Jun 2017 to Jun 2019
  • Muscle Relaxant3 · Jun 2017 to Jun 2019
  • Pain Management3 · Jun 2017 to Jun 2019
  • Respiratory3 · Jun 2017 to Jun 2019
  • Thyroid Deficiency3 · Jun 2017 to Jun 2019
  • Methylphenidate Hydrochloride1 · Mar 2020

Statement business segments1 member · 7 facts

  • Generic Pharmaceutical Member7 · Mar 2016 to Mar 2017

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of LANNETT COMPANY, INC (LCI) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.

LANNETT COMPANY, INC (LCI): FY2022 revenue $341M · FactIQ